103 related articles for article (PubMed ID: 1268845)
1. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
Kawana T; Cornish JD; Smith MF; Aurelian L
Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
[TBL] [Abstract][Full Text] [Related]
2. Herpesvirus type 2-induced tumour-specific antigen (AG-4) and specific antibody in patients with cervical cancer and controls.
Aurelian L; Cornish JD; Smith MF
IARC Sci Publ (1971); 1975; (11 Pt 2):79-87. PubMed ID: 191387
[No Abstract] [Full Text] [Related]
3. Frequency of anti-AG-4 antibody in patients with uterine cervical cancer and controls.
Kawana T; Sakamoto S; Kasamatsu T; Aurelian L
Gan; 1978 Aug; 69(4):589-91. PubMed ID: 710808
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to herpesvirus type 1 and type 2 among Japanese cervical cancer patients.
Ozaki Y; Ishiguro T; Ohashi M; Sawaragi I; Ito Y
Gan; 1978 Feb; 69(1):119-22. PubMed ID: 640320
[TBL] [Abstract][Full Text] [Related]
5. Neutralization, immunofluorescence and complement fixation tests in identification of antibody to a herpesvirus type 2-induced, tumor-specific antigen in sera from squamous cervical carcinoma.
Aurelian L; Strandberg JD; Marcus RL
Prog Exp Tumor Res; 1974; 19():165-81. PubMed ID: 4612606
[No Abstract] [Full Text] [Related]
6. Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.
Aurelian L; Kessler II; Rosenshein NB; Barbour G
Cancer; 1981 Jul; 48(2 Suppl):455-71. PubMed ID: 7023662
[TBL] [Abstract][Full Text] [Related]
7. Antibody to HSV-2 induced tumor specific antigens in serums from patients with cervical carcinoma.
Aurelian L; Schumann B; Marcus RL; Davis HJ
Science; 1973 Jul; 181(4095):161-4. PubMed ID: 4711734
[TBL] [Abstract][Full Text] [Related]
8. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
Notter MF; Docherty JJ
Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes in carcinoma of uterine cervix.
Seth P; Balachandran N; Malaviya AN; Kumar R
Clin Exp Immunol; 1979 Oct; 38(1):77-82. PubMed ID: 527257
[TBL] [Abstract][Full Text] [Related]
10. Possible role of Herpesvirus hominis, type 2, in human cervical cancer.
Aurelian L
Fed Proc; 1972; 31(6):1651-9. PubMed ID: 4351374
[No Abstract] [Full Text] [Related]
11. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of serum antibodies to LA-1 oncoprotein, herpes simplex virus type-2 glycoprotein and human papillomavirus type 16 transactivator (E2) protein among Indian women with cervical neoplasia.
Sharma BK; Sharma R; Smith CC; Aurelian L
Indian J Exp Biol; 1998 Oct; 36(10):967-72. PubMed ID: 10356958
[TBL] [Abstract][Full Text] [Related]
13. Genital herpes virus findings in relation to cervical neoplasia.
Royston I; Aurelian L; Davis HJ
J Reprod Med; 1970 Apr; 4(4):9-13. PubMed ID: 4328889
[No Abstract] [Full Text] [Related]
14. Herpes type-2 virus antibody status in groups of patients with neoplasm in Ibadan.
Adelusi B; Osunkoya BO; Fabiyi A
Afr J Med Med Sci; 1976 Dec; 5(4):297-301. PubMed ID: 204178
[TBL] [Abstract][Full Text] [Related]
15. IgM antibody to a tumor-associated antigen (AG-4) induced by herpes simplex virus type 2: its use in location of the antigen in infected cells.
Aurelian L; Smith MF; Cornish DJ
J Natl Cancer Inst; 1976 Mar; 56(3):471-7. PubMed ID: 176392
[TBL] [Abstract][Full Text] [Related]
16. Tumor-associated antigens in cervical cancer tissues and in sera from patients with cervical cancer or with head and neck cancer.
Ibrahim AN; Robinson RA; Marr L; Abdelal AT; Nahmias AJ
J Natl Cancer Inst; 1979 Aug; 63(2):319-23. PubMed ID: 88537
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen: clinical utility in squamous cell carcinoma of the uterine cervix.
Bolli JA; Doering DL; Bosscher JR; Day TG; Rao CV; Owens K; Kelly B; Goldsmith J
Gynecol Oncol; 1994 Nov; 55(2):169-73. PubMed ID: 7959279
[TBL] [Abstract][Full Text] [Related]
18. A population-based seroepidemiological study of cervical cancer.
Dillner J; Lenner P; Lehtinen M; Eklund C; Heino P; Wiklund F; Hallmans G; Stendahl U
Cancer Res; 1994 Jan; 54(1):134-41. PubMed ID: 8261434
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to herpesvirus nonvirion antigens in squamous carcinomas.
Hollinshead AC; Lee O; Chretien PB; Tarpley JL; Rawls WE; Adam E
Science; 1973 Nov; 182(4113):713-5. PubMed ID: 4752210
[TBL] [Abstract][Full Text] [Related]
20. Herpesvirus type 2-related antigens and their relevance to humoral and cell-mediated immunity in patients with cervical cancer.
Aurelian L; Strnad BC
Cancer Res; 1976 Feb; 36(2 pt 2):810-20. PubMed ID: 175945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
